Literature DB >> 21930345

Hypothalamic-pituitary-adrenal axis and clinical symptoms in first-episode psychosis.

Martino Belvederi Murri1, Carmine M Pariante, Paola Dazzan, Nilay Hepgul, Andrew S Papadopoulos, Patricia Zunszain, Marta Di Forti, Robin M Murray, Valeria Mondelli.   

Abstract

BACKGROUND: Abnormalities in hypothalamic-pituitary-adrenal (HPA) axis activity have been reported in patients with psychosis, but it is still unclear how these are related to the clinical symptomatology. Inconsistent findings have emerged from previous studies on the association between cortisol levels and clinical symptoms. Methodological and/or clinical factors, such as patients' diagnosis or illness phase, might partially account for these inconsistencies. The aim of this study was to investigate the association between HPA axis activity and clinical symptoms in first-episode psychosis, taking into account diagnosis and illness phase.
METHOD: Saliva samples were collected in 55 subjects with first-episode psychosis to assess the Cortisol Awakening Response (CAR) and diurnal cortisol levels (AUC-DAY). Severity of symptoms was assessed with the Positive and Negative Syndrome Scale (PANSS). Scores for subscales and symptom dimensions were used as predictors in multivariate analyses in different diagnostic subgroups and in clinically remitted patients. In addition, a systematic review of the literature on this topic was conducted.
RESULTS: In subjects with schizophrenia (n=36), the CAR was predicted by the severity of positive symptoms (beta=0.47, p=0.04); in subjects with depressive psychoses (n=8) the CAR was predicted by excitement (beta=0.58, p=0.005), disorganization (beta=0.39, p=0.007) and depressive symptoms (beta=0.32, p=0.005). In patients with bipolar psychoses (n=11) AUC-DAY was predicted negatively by disorganization (beta=-2.82, p=0.009) and positively by excitement (beta=2.06, p=0.009) and positive symptoms (beta=1.28, p=0.02). In the sample in clinical remission (n=9), the CAR was associated with the severity of positive symptoms (beta=1.34, p=0.009) and, negatively, with excitement (beta=-1.05, p=0.04). The systematic review (on a total of 28 papers, including n=1022 patients), found that in patients with psychosis cortisol levels have been associated with the severity of multiple symptom dimensions.
CONCLUSIONS: HPA axis activity is associated with the severity of multiple types of symptoms in first-episode psychosis. Patients' diagnosis and clinical phase partially influence these associations. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21930345     DOI: 10.1016/j.psyneuen.2011.08.013

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  23 in total

1.  Cortisol Reactivity to Stress and Its Association With White Matter Integrity in Adults With Schizophrenia.

Authors:  Katie L Nugent; Joshua Chiappelli; Hemalatha Sampath; Laura M Rowland; Kavita Thangavelu; Beshaun Davis; Xiaoming Du; Florian Muellerklein; Stacey Daughters; Peter Kochunov; L Elliot Hong
Journal:  Psychosom Med       Date:  2015-09       Impact factor: 4.312

Review 2.  Stress and neurodevelopmental processes in the emergence of psychosis.

Authors:  C W Holtzman; H D Trotman; S M Goulding; A T Ryan; A N Macdonald; D I Shapiro; J L Brasfield; E F Walker
Journal:  Neuroscience       Date:  2013-01-05       Impact factor: 3.590

3.  Childhood predictors of written expression in late adolescents with 22q11.2 deletion syndrome: a longitudinal study.

Authors:  N Hamsho; K M Antshel; T L Eckert; W R Kates
Journal:  J Intellect Disabil Res       Date:  2017-03-08

4.  Cumulative stress pathophysiology in schizophrenia as indexed by allostatic load.

Authors:  Katie L Nugent; Joshua Chiappelli; Laura M Rowland; L Elliot Hong
Journal:  Psychoneuroendocrinology       Date:  2015-06-21       Impact factor: 4.905

5.  The relationship between cannabis use and cortisol levels in youth at ultra high-risk for psychosis.

Authors:  Emily E Carol; Robert L Spencer; Vijay A Mittal
Journal:  Psychoneuroendocrinology       Date:  2017-05-30       Impact factor: 4.905

6.  HPA-axis function, symptoms, and medication exposure in youths at clinical high risk for psychosis.

Authors:  G Sugranyes; J L Thompson; C M Corcoran
Journal:  J Psychiatr Res       Date:  2012-08-11       Impact factor: 4.791

7.  Resting cortisol level, self-concept, and putative familial environment in adolescents at ultra high-risk for psychotic disorders.

Authors:  Emily E Carol; Vijay A Mittal
Journal:  Psychoneuroendocrinology       Date:  2015-03-28       Impact factor: 4.905

8.  Neuroendocrine profile in a rat model of psychosocial stress: relation to oxidative stress.

Authors:  Marilena Colaianna; Stefania Schiavone; Margherita Zotti; Paolo Tucci; Maria Grazia Morgese; Liselotte Bäckdahl; Rikard Holmdahl; Karl-Heinz Krause; Vincenzo Cuomo; Luigia Trabace
Journal:  Antioxid Redox Signal       Date:  2013-04-20       Impact factor: 8.401

9.  Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study.

Authors:  Elaine F Walker; Hanan D Trotman; Brad D Pearce; Jean Addington; Kristin S Cadenhead; Barbara A Cornblatt; Robert Heinssen; Daniel H Mathalon; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Tyrone D Cannon; Thomas H McGlashan; Scott W Woods
Journal:  Biol Psychiatry       Date:  2013-04-03       Impact factor: 13.382

Review 10.  The role of cortisol in first episode of psychosis: a systematic review.

Authors:  Evangelos Karanikas; Diomidis Antoniadis; George D Garyfallos
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.